Sign Out
Cefacef is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis.
Otitis media caused by Haemophilus influenzae (β-lactamase-positive and -negative strains), Moraxella (Branhamella) catarrhalis (most of which are β-lactamase-positive) and Streptococcus pyogenes.
Pharyngitis and tonsillitis caused by Streptococcus pyogenes.
Acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae (β-lactamase-positive and -negative strains).
Treatment of typhoid fever in children with multi-resistant to standard treatment.
Uncomplicated gonorrhea (cervical/urethral) caused by Neisseria gonorrhoeae (penicillinase and nonpenicillinase-producing strains).
